Skip to main content

Table 2 2a. Aortic regurgitation incidence (percent per year) estimated from Framingham Study prevalence (Singh, et al, 1999). Prevalence of mild or greater aortic regurgitation utilized.

From: Risk of valvular heart disease associated with use of fenfluramine

  Men Women
Age N Prevalence (%) Incidence N Prevalence (%) Incidence
26–39 91 0 - 93 0 -
40–49 352 1.7 0.171 451 0.7 0.070
50–59 433 4.2 0.253 515 2.1 0.141
60–69 359 12.7 0.884 390 6.8 0.480
70–83 91 14.4 0.132 90 16.9 0.816
2b. Mitral regurgitation incidence estimated from Framingham Study prevalence rates (Singh, et al, 1999). Prevalence of moderate or greater mitral regurgitation utilized.
  Men Women
Age N Prevalence (%) Incidence N Prevalence (%) Incidence
26–39 91 0 - 93 0 -
40–49 351 0.3 0.030 452 0.9 0.090
50–59 432 1.6 0.131 515 1.0 0.010
60–69 372 2.4 0.080 395 2.3 0.131
70–83 90 11.2 0.706 90 0.0 0.000